The use of in vitro cell culture models for mechanistic studies and as permeability screens for the blood–brain barrier in the pharmaceutical industry—Background and current status in the drug discovery process

Audus, 1988, Bovine brain microvessel endothelial cell monolayers as a model system for the blood–brain barrier, Ann. N.Y. Acad. Sci., 507, 9, 10.1111/j.1749-6632.1987.tb45787.x

Begley, 1996, Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4, J. Neurochem., 67, 988, 10.1046/j.1471-4159.1996.67030988.x

Claudio, 1989, Increased vesicular transport and decreased mitochondrial content in blood–brain barrier endothelial cells during experimental autoimmune encephalomyelitis, Am. J. Pathol., 135, 446

Claudio, 1995, Evidence of persistent blood–brain barrier abnormalities in chronic-progressive multiple sclerosis, Acta Neuropathol., 90, 228, 10.1007/BF00296505

Dehouck, 1990, An easier, reproducible and mass production method to study the blood–brain barrier in vitro, J. Neurochem., 54, 1798, 10.1111/j.1471-4159.1990.tb01236.x

Dehouck, 1994, Upregulation of the low density lipoprotein receptor at the blood–brain barrier: intercommunications between brain capillary endothelial cells and astrocytes, J. Cell Biol., 126, 456, 10.1083/jcb.126.2.465

Franke, 1999, An improved low permeability in vitro model of the blood–brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol, Brain Res., 818, 65, 10.1016/S0006-8993(98)01282-7

Joó, 1985, The blood–brain barrier in vitro: ten years of research on microvessels isolated from the brain, Neurochem. Int., 7, 1, 10.1016/0197-0186(85)90002-6

Kwon, 1994, Blood–brain barrier abnormalities in long-standing multiple sclerosis lesions. An immunohistochemical study, J. Neuropathol. Exp. Neurol., 53, 625, 10.1097/00005072-199411000-00010

Méresse, 1989, Bovine brain endothelial cells express tight-junctions and monoamine oxidase activity in long term culture, J. Neurochem., 53, 1363, 10.1111/j.1471-4159.1989.tb08526.x

Plateel, 1995, Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood–brain barrier endothelial cell monolayer, J. Neurochem., 65, 2138, 10.1046/j.1471-4159.1995.65052138.x

Plateel, 1997, Hypoxia dramatically increases the nonspecific transport of blood-borne proteins to the brain, J. Neurochem., 68, 1, 10.1046/j.1471-4159.1997.68020874.x

Prentis, 1988, Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964–1985), Br. J. Clin. Pharmacol., 25, 387, 10.1111/j.1365-2125.1988.tb03318.x

Reichel, 2000, Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood–brain barrier, J. Cereb. Blood Flow Metab., 20, 168, 10.1097/00004647-200001000-00021

Rist, 1997, F-actin cytoskeleton and sucrose permeability of immortalised rat brain microvascular endothelial cell monolayers: effects of cyclic AMP and astrocytic factors, Brain Res., 768, 10, 10.1016/S0006-8993(97)00586-6

Rubin, 1991, A cell culture model of the blood–brain barrier, J. Cell Biol., 115, 1725, 10.1083/jcb.115.6.1725

Zetter, 1988, Endothelial heterogeneity: influence of vessel size, organ localization and species specificity on the properties of cultured endothelial cells, vol. II, 63